Aims Intra-aortic balloon counterpulsation (IABP) in ST-segment elevation myocardial
infarction (STEMI) with cardiogenic shock is strongly recommended (class IB) in the current …

Objectives: This study was designed to determine: 1) whether a routine invasive (RI) strategy
reduces the long-term frequency of cardiovascular death or nonfatal myocardial infarction …

Objective: To review our current understanding of the epidemiology and pathogenesis of
vein graft failure (VGF), give an overview of current preventive and interventional measures …

Background Current guidelines recommend an early invasive strategy for patients who have
acute coronary syndromes without ST-segment elevation and with an elevated cardiac …

Background: Despite advances in treatment, mortality in acute myocardial infarction (AMI)
complicated by cardiogenic shock (CS) remains high. Short-term mechanical circulatory …

Background Bioresorbable vascular scaffolds were developed to overcome the
shortcomings of drug-eluting stents in percutaneous coronary intervention (PCI). We …

Context Although an invasive strategy is frequently used in patients with non–ST-segment
elevation acute coronary syndromes (NSTE ACS), data from some trials suggest that this …

Background—Acute ST-elevation myocardial infarction (STEMI) is caused by sudden
occlusive coronary thrombosis, after plaque disruption; however, a considerable time …

Background—Discordance between fractional flow reserve (FFR) and coronary flow velocity
reserve (CFVR) may reflect important coronary pathophysiology but usually remains …

To the Editor: Recognition of characteristic changes in an electrocardiogram (ECG) that are
associated with acute occlusion of a coronary artery guides decisions regarding immediate …